Open Forum on Neuromyelitis Optica Spectrum Disorder
June 21 @ 1:00 pm, EDT - 2:00 pm, EDT
SEND US YOUR QUESTIONS FOR THE EXPERTS HERE
(During the podcast, you can interact with the moderator through our TMA Facebook page, or using the chat function in GoToWebinar)
Maureen Mealy, RN, BSN, MSCN
Maureen Mealy is a Clinical Program Manager at Johns Hopkins Transverse Myelitis Center and Neuromyelitis Optica Clinic in Baltimore, MD. Maureen is a certified Clinical Neuroscience Registered Nurse and a Multiple Sclerosis Certified Nurse. She has longstanding experience in neurosciences as she began her nursing career in the Neurosciences Critical Care Unit at the Johns Hopkins Hospital and later joined the Johns Hopkins Multiple Sclerosis, Transverse Myelitis, and Encephalitis Centers in January of 2007. Ms. Mealy then moved to Dallas along with Dr. Benjamin Greenberg, former co-Director of the Johns Hopkins Transverse Myelitis Center, to establish the Transverse Myelitis and Neuromyelitis Optica Program at the University of Texas Southwestern University and Pediatric Demyelinating Disorders at Children’s Medical Center of Dallas in January of 2009. More recently, Ms. Mealy rejoined Johns Hopkins and teamed up with Drs. Carlos Pardo and Michael Levy, where she currently acts as the Program Manager, Clinical Research Coordinator, and Senior Nurse of the Transverse Myelitis Center and Neuromyelitis Optica Clinic.
Michael Levy, MD, PhD
Dr. Michael Levy is an Associate Professor of Neurology and the Medical Director of General Neurology at the Johns Hopkins Hospital in Baltimore, MD. Dr. Levy specializes in taking care of patients with neuroimmunologic diseases including multiple sclerosis, transverse myelitis, optic neuritis and neuromyelitis optica. In the laboratory, Dr. Levy¹s research focus is on the development of neural stems for regenerative therapy in these diseases. He uses rat and mouse models to test the survival, differentiation and functional capacity of human neural stem cells to improve neurologic function in post-inflammatory conditions. The goal of his laboratory and clinical effort is to translate the basic science stem cell work to a human trial in transverse myelitis and other neuroimmunologic diseases.
Listen to previous Ask the Expert podcasts here
JUNE 2017 ASK THE EXPERT PODCAST SERIES SPONSORED BY
Alexion is a global biopharmaceutical company focused on serving patients with severe and rare disorders through the innovation, development and commercialization of life-transforming therapeutic products. Their goal to deliver medical breakthroughs where none currently exist is driven by the knowledge that people’s lives depend on their work.
* The Executive Committee of the TMA with the medical and scientific council determines the content and topics of the podcasts. Sponsors are not able to influence the education program.